The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
We started a company uh with Paul Ketta um called Vero Biosciences. Vero Vero Biosciences. And the mission is really to profile the age of organs to ideally eradicate chronic diseases and to um maintain or to predict which organ is going to age. Because what we find is that if you have an organ that ages faster, if you can detect that and you can do an intervention, you can potentially delay aging, right? And extend health span. And this is really the mission of uh of Vero.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.